Table 1

Baseline clinical characteristics of the patients who completed the study

VariableBasal-bolus groupPremixed insulin groupP value
Patients, n3339
Sex0.96
 Male10 (30.3)12 (30.8)
 Female23 (69.7)27 (69.2)
Age, years67.5 ± 11.075.3 ± 9.50.002
BMI, kg/m229.5 ± 6.927.3 ± 4.60.15
Body weight, kg80.9 ± 22.374.0 ± 12.40.11
Duration of diabetes, years13.4 ± 10.317.2 ± 11.30.19
Hospital admission service
 Medicine22 (66.7)16 (42.1)0.038
 Surgery11 (33.3)22 (57.9)
Hospital LOS, days17.4 ± 17.324.1 ± 18.40.13
Hospital admission diabetes therapy0.63
 Diet alone4 (12.1)7 (17.9)
 Oral agents13 (40.6)11 (28.2)
 Insulin alone8 (25.0)15 (38.5)
 Insulin and oral agents8 (25.0)6 (15.4)
Primary diagnosis0.15
 Cardiovascular16 (48.5)13 (33.3)
 Pulmonary3 (9.1)1 (2.6)
 Soft-tissue and foot infection11 (33.3)23 (59)
 Other3 (9.1)2 (5.1)
Glycemic control
 HbA1c0.78
  %8.5 ± 1.88.6 ± 2.0
  mmol/mol69.7 ± 19.971.1 ± 22.4
 Hospital admission BG, mg/dL203.1 ± 105221.3 ± 104.60.47
 Randomization BG, mg/dL221.2 ± 76210.5 ± 570.52
  • Data are n (%) or mean ± SD, unless otherwise indicated. LOS, length of stay.